Professional Summary

Professional Overview

Mark Bradley is an accomplished Chief Financial Officer with extensive experience in the pharmaceutical industry. He specializes in corporate finance, strategic planning, and business development, driving financial performance and operational efficiency for organizations.

Experience Summary

Current Role

As the Chief Financial Officer of Endo, Mark is responsible for overseeing the company's financial operations, including financial planning, reporting, and risk management. He plays a pivotal role in shaping Endo's strategic direction, identifying growth opportunities, and ensuring financial resilience amidst industry challenges.

Career Progression

Prior to his current role, Mark served as the Senior Vice President of Corporate Development and Treasurer at Endo, where he spearheaded mergers and acquisitions, strategic partnerships, and capital allocation initiatives. He has also held senior finance positions at GrafTech International and management consulting roles at Deloitte, PricewaterhouseCoopers, and Cap Gemini, leveraging his expertise in strategy, operations, and financial advisory.

Academic Background

Mark holds a Bachelor's degree in Accounting from the University of Pennsylvania, where he graduated with distinction. He is a Certified Public Accountant (CPA) and has completed executive education programs at prestigious institutions, further enhancing his financial acumen and strategic leadership capabilities.

Areas of Expertise

• Corporate finance and treasury management

• Strategic planning and business development

• Mergers, acquisitions, and integration

• Financial reporting and risk management

• Operational optimization and cost containment

• Leadership and team development

Professional Impact

Throughout his career, Mark has demonstrated a track record of driving financial performance and operational efficiency for the organizations he has served. He has played a crucial role in shaping Endo's growth strategy, securing strategic partnerships, and ensuring the company's financial resilience during challenging market conditions.

Conclusion

With his extensive experience, strong financial expertise, and strategic mindset, Mark Bradley is a valuable asset to Endo, driving the company's financial and operational success. His commitment to excellence and proven ability to navigate complex business environments make him a respected leader in the pharmaceutical industry.